Compare $BCLI vs $SNTI | Chartloom

Compare

$BCLI vs $SNTI

Brainstorm Cell Therapeutics Inc · Senti Biosciences Inc

BCLI

Brainstorm Cell Therapeutics Inc

SNTI

Senti Biosciences Inc

Compare $BCLI vs $SNTI

Comparing Brainstorm Cell Therapeutics Inc and Senti Biosciences Inc

BCLIBrainstorm Cell Therapeutics Inc

SNTISenti Biosciences Inc

BCLIBrainstorm Cell Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

54.9%

52W performance

30.1%

FCF yield

-21.1%

SNTISenti Biosciences Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-71.4%

52W performance

-82.3%

FCF yield

-388.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCLI

SNTI

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

SNTI

Senti Biosciences Inc

Market Cap

BCLI$10M

SNTI$10M

Enterprise Value

BCLI$12M

SNTI$7M

Price

BCLI$0.95

SNTI$0.31

P/E Ratio

BCLIN/A

SNTIN/A

P/S Ratio

BCLI0.00x

SNTI178.01x

EV/Sales

BCLI0.00x

SNTI133.10x

EV/EBITDA

BCLI0.00x

SNTI0.00x

P/B Ratio

BCLI7.31x

SNTI3.91x

P/FCF Ratio

BCLIN/A

SNTIN/A

EV/FCF

BCLI-5.29x

SNTI-0.19x

PEG Ratio

BCLIN/A

SNTIN/A

Forward P/E (NTM)

BCLIN/A

SNTIN/A

Forward P/S (NTM)

BCLIN/A

SNTIN/A

Revenue (TTM)

BCLI$0

SNTI$55K

Revenue Growth (YoY)

BCLIN/A

SNTIN/A

Forward Rev Growth

BCLI53.7%

SNTI-13.8%

Gross Margin (TTM)

BCLI0.0%

SNTI0.0%

Operating Margin (TTM)

BCLI0.0%

SNTI0.0%

EBITDA Margin (TTM)

BCLI0.0%

SNTI-97030.9%

Net Margin (TTM)

BCLI0.0%

SNTI-90116.4%

FCF Margin (TTM)

BCLIN/A

SNTI-69183.6%

Net Income (TTM)

BCLI$-7M

SNTI$-50M

FCF (TTM)

BCLI$-2M

SNTI$-38M

EPS (TTM)

BCLI-$0.61

SNTI-$1.59

ROE (TTM)

BCLI-23636.0%

SNTI-50379.0%

ROA (TTM)

BCLI-33822.0%

SNTI-11312.0%

ROIC (TTM)

BCLI-23636.0%

SNTI-50379.0%

Cash

BCLI$22K

SNTI$6M

Debt

BCLI$1M

SNTI$4M

Net Cash/Debt

BCLI$-1M

SNTI$2M

Current Ratio (TTM)

BCLI0.21x

SNTI0.83x

Quick Ratio (TTM)

BCLI0.16x

SNTI0.47x

Debt/Equity (TTM)

BCLI0.00x

SNTI0.00x

Debt/Assets (TTM)

BCLI0.0%

SNTI0.0%

Interest Coverage (TTM)

BCLIN/A

SNTIN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

SNTI0.00x

Beta

BCLI0.39

SNTI2.28

52W Performance

BCLI30.1%

SNTI-82.3%

YTD Performance

BCLI54.9%

SNTI-71.4%

% from 52W High

BCLI-43.8%

SNTI-89.1%

% from 52W Low

BCLI106.9%

SNTI8.4%

Asset Turnover (TTM)

BCLI0.00x

SNTI0.00x

FCF Yield (TTM)

BCLI-21.1%

SNTI-388.7%

Earnings Yield (TTM)

BCLI-64.2%

SNTI-506.3%

Dividend Yield (TTM)

BCLIN/A

SNTIN/A

Rule of 40

BCLI0.0

SNTI-69,183.6

EV/GP/RG

BCLIN/A

SNTIN/A

Ticker research

View BCLI research View SNTI research

Metric	BCLI Brainstorm Cell Therapeutics Inc	SNTI Senti Biosciences Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$12M	$7M
Price	$0.95	$0.31
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	178.01x
EV/Sales	0.00x	133.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.31x	3.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$55K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	53.7%	-13.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-97030.9%
Net Margin (TTM)	0.0%	-90116.4%
FCF Margin (TTM)	N/A	-69183.6%
Net Income (TTM)	$-7M	$-50M
FCF (TTM)	$-2M	$-38M
EPS (TTM)	-$0.61	-$1.59
ROE (TTM)	-23636.0%	-50379.0%
ROA (TTM)	-33822.0%	-11312.0%
ROIC (TTM)	-23636.0%	-50379.0%
Financial Health
Cash	$22K	$6M
Debt	$1M	$4M
Net Cash/Debt	$-1M	$2M
Current Ratio (TTM)	0.21x	0.83x
Quick Ratio (TTM)	0.16x	0.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	2.28
52W Performance	30.1%	-82.3%
YTD Performance	54.9%	-71.4%
% from 52W High	-43.8%	-89.1%
% from 52W Low	106.9%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.1%	-388.7%
Earnings Yield (TTM)	-64.2%	-506.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-69,183.6
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View SNTI research

Valuation

P/S Ratio

BCLI

0.00x

SNTI

178.01x

EV/FCF

BCLI

-5.29x

SNTI

-0.19x

Growth & revenue

Forward Revenue Growth

BCLI

53.7%

SNTI

-13.8%

Profitability & performance

Gross Margin

BCLI

0.0%

SNTI

0.0%

ROE

BCLI

-23636.0%

SNTI

-50379.0%

FCF Yield %

BCLI

-21.1%

SNTI

-388.7%

52-Week Performance

BCLI

30.1%

SNTI

-82.3%

Detailed metrics comparison

BCLI

Brainstorm Cell Therapeutics Inc

SNTI

Senti Biosciences Inc

Market Cap

BCLI$10M

SNTI$10M

Enterprise Value

BCLI$12M

SNTI$7M

Price

BCLI$0.95

SNTI$0.31

P/E Ratio

BCLIN/A

SNTIN/A

P/S Ratio

BCLI0.00x

SNTI178.01x

EV/Sales

BCLI0.00x

SNTI133.10x

EV/EBITDA

BCLI0.00x

SNTI0.00x

P/B Ratio

BCLI7.31x

SNTI3.91x

P/FCF Ratio

BCLIN/A

SNTIN/A

EV/FCF

BCLI-5.29x

SNTI-0.19x

PEG Ratio

BCLIN/A

SNTIN/A

Forward P/E (NTM)

BCLIN/A

SNTIN/A

Forward P/S (NTM)

BCLIN/A

SNTIN/A

Revenue (TTM)

BCLI$0

SNTI$55K

Revenue Growth (YoY)

BCLIN/A

SNTIN/A

Forward Rev Growth

BCLI53.7%

SNTI-13.8%

Gross Margin (TTM)

BCLI0.0%

SNTI0.0%

Operating Margin (TTM)

BCLI0.0%

SNTI0.0%

EBITDA Margin (TTM)

BCLI0.0%

SNTI-97030.9%

Net Margin (TTM)

BCLI0.0%

SNTI-90116.4%

FCF Margin (TTM)

BCLIN/A

SNTI-69183.6%

Net Income (TTM)

BCLI$-7M

SNTI$-50M

FCF (TTM)

BCLI$-2M

SNTI$-38M

EPS (TTM)

BCLI-$0.61

SNTI-$1.59

ROE (TTM)

BCLI-23636.0%

SNTI-50379.0%

ROA (TTM)

BCLI-33822.0%

SNTI-11312.0%

ROIC (TTM)

BCLI-23636.0%

SNTI-50379.0%

Cash

BCLI$22K

SNTI$6M

Debt

BCLI$1M

SNTI$4M

Net Cash/Debt

BCLI$-1M

SNTI$2M

Current Ratio (TTM)

BCLI0.21x

SNTI0.83x

Quick Ratio (TTM)

BCLI0.16x

SNTI0.47x

Debt/Equity (TTM)

BCLI0.00x

SNTI0.00x

Debt/Assets (TTM)

BCLI0.0%

SNTI0.0%

Interest Coverage (TTM)

BCLIN/A

SNTIN/A

Net Debt/EBITDA (TTM)

BCLI0.00x

SNTI0.00x

Beta

BCLI0.39

SNTI2.28

52W Performance

BCLI30.1%

SNTI-82.3%

YTD Performance

BCLI54.9%

SNTI-71.4%

% from 52W High

BCLI-43.8%

SNTI-89.1%

% from 52W Low

BCLI106.9%

SNTI8.4%

Asset Turnover (TTM)

BCLI0.00x

SNTI0.00x

FCF Yield (TTM)

BCLI-21.1%

SNTI-388.7%

Earnings Yield (TTM)

BCLI-64.2%

SNTI-506.3%

Dividend Yield (TTM)

BCLIN/A

SNTIN/A

Rule of 40

BCLI0.0

SNTI-69,183.6

EV/GP/RG

BCLIN/A

SNTIN/A

Ticker research

View BCLI research View SNTI research

Metric	BCLI Brainstorm Cell Therapeutics Inc	SNTI Senti Biosciences Inc
Market & Valuation
Market Cap	$10M	$10M
Enterprise Value	$12M	$7M
Price	$0.95	$0.31
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	178.01x
EV/Sales	0.00x	133.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.31x	3.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.29x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$55K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	53.7%	-13.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-97030.9%
Net Margin (TTM)	0.0%	-90116.4%
FCF Margin (TTM)	N/A	-69183.6%
Net Income (TTM)	$-7M	$-50M
FCF (TTM)	$-2M	$-38M
EPS (TTM)	-$0.61	-$1.59
ROE (TTM)	-23636.0%	-50379.0%
ROA (TTM)	-33822.0%	-11312.0%
ROIC (TTM)	-23636.0%	-50379.0%
Financial Health
Cash	$22K	$6M
Debt	$1M	$4M
Net Cash/Debt	$-1M	$2M
Current Ratio (TTM)	0.21x	0.83x
Quick Ratio (TTM)	0.16x	0.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	2.28
52W Performance	30.1%	-82.3%
YTD Performance	54.9%	-71.4%
% from 52W High	-43.8%	-89.1%
% from 52W Low	106.9%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.1%	-388.7%
Earnings Yield (TTM)	-64.2%	-506.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-69,183.6
EV/GP/RG	N/A	N/A
Ticker research	View BCLI research	View SNTI research